Group 1 - The core viewpoint of the news is that He Yuan Bio has seen a continuous increase in stock price, with a 6.57% rise over three days, reaching a price of 83.00 yuan per share and a market capitalization of 29.673 billion yuan [1] - He Yuan Bio, established on November 16, 2006, specializes in the research, production, and sales of plant-derived human serum albumin using rice endosperm cell recombinant protein expression technology, with 75.44% of its revenue coming from recombinant human albumin [1] - The stock has a trading volume of 2.17 billion yuan and a turnover rate of 6.52% as of the report date [1] Group 2 - According to data, the Industrial Bank of China Credit Fund holds He Yuan Bio as its fifth-largest position, with 16,500 shares representing 0.02% of the fund's net value, yielding a floating profit of approximately 11,500 yuan today and 84,300 yuan over the three-day increase [2] - The fund, named Industrial Bank of China Science and Technology ETF Link A (011614), was established on March 5, 2021, with a current scale of 1.494 billion yuan and has achieved a year-to-date return of 13.15% [2] - The fund's one-year return is 54.14%, ranking 42 out of 209 in its category, while its total return since inception is 19.72% [2] Group 3 - The fund manager of Industrial Bank of China Science and Technology ETF Link A is Zhao Xu, who has a total tenure of 14 years and 106 days, managing assets totaling 68.885 billion yuan [3] - During Zhao Xu's tenure, the best fund return achieved was 233.59%, while the worst return was -84.87% [3]
禾元生物股价连续3天上涨累计涨幅6.57%，工银瑞信基金旗下1只基金持1.65万股，浮盈赚取8.43万元